Novo Nordisk A/S
Stocks making the biggest moves midday: Kohl’s, Best Buy, Zoom Communications, Stellantis and more
Check out the companies making headlines in midday trading. Kohl’s – Shares tumbled 18% after the retailer cut its sales outlook amid an uncertain holiday backdrop . The latest quarter’s earnings and sales fell short of Wall Street analysts’ estimates, and the CEO will step down in January. Amgen — The biotech fell more than […]
Read More
Amgen says obesity drug caused up to 20% weight loss after a year, with no plateau
The Amgen logo is displayed outside Amgen headquarters in Thousand Oaks, California, on May 17, 2023. Mario Tama | Getty Images Amgen on Tuesday said its experimental weight loss injection helped patients with obesity lose up to 20% of their weight on average after a year in a critical mid-stage trial, as the company races […]
Read More
Biden proposes Medicare and Medicaid cover costly weight-loss drugs for millions of obese Americans
Boxes of Ozempic and Wegovy made by Novo Nordisk are seen at a pharmacy in London, Britain March 8, 2024. Hollie Adams | Reuters Millions of Americans with obesity would be eligible to have popular weight-loss drugs like Wegovy or Ozempic covered by Medicare or Medicaid under a new rule the Biden administration proposed Tuesday […]
Read More
Barclays says these global stocks are ripe for share buybacks — and analysts give one 45% upside
European equity markets might look “gloomy” right now, but Barclays noted that one investment strategy has delivered “solid outperformance” over recent months. “Buyback strategies remain a bright spot for Europe, with strong volumes and returns. Amid a gloomy equity market, our buyback announcement basket (BCEUBUYB) has outperformed by 4.6% since Oct,” the investment bank’s strategists […]
Read More
Global equity returns are disappearing as U.S. stock market rockets higher
The U.S. stock market has been having a party for most of November, but it hasn’t invited the rest of the world to join the fun. As the market turned mixed following early losses Tuesday, the S & P 500 and other major averages have posted solid gains during the month. The large-cap benchmark is […]
Read More
How we’re thinking about Eli Lilly after Trump picked obesity-drug critic RFK Jr. to run HHS
Enthusiasm for Club holding Eli Lilly needs to be tempered — at least for now — as Wall Street grapples with the possibility of a major shakeup to health policy in Washington. The news Republican President-elect Donald Trump on Thursday nominated prominent vaccine skeptic and obesity-drug critic Robert F. Kennedy Jr. to lead the Department […]
Read More
Stocks making the biggest moves midday: Palantir, Moderna, Ulta Beauty, Alibaba and more
Check out the companies making headlines in midday trading. Global pharma stocks — Shares of several vaccine makers declined after President-elect Donald Trump selected prominent vaccine skeptic Robert F. Kennedy Jr. as health secretary on Thursday. Shares of Moderna and Pfizer slipped nearly 9% and 5%, respectively. BioNTech , which helped develop a Covid vaccine with […]
Read More
Philippe Laffont’s Coatue makes big bets on China and GLP-1 drugmakers in latest quarter
Philippe Laffont’s Coatue Management took several new stakes in major Chinese e-commerce companies and a couple of anti-obesity focused drugmakers in the third quarter, according to the latest 13F filing with the U.S. Securities and Exchange Commission. Laffont, one of the “Tiger Cub” fund managers who worked under the late Julian Robertson at Tiger Management, […]
Read More
Amgen stock falls as analysts mull over weight loss drug’s bone density data
Omar Marques | Lightrocket | Getty Images Shares of Amgen fell more than 7% Tuesday as analysts chewed over bone density loss data from an early-stage trial on its experimental weight loss injection, MariTide. One analyst said the additional data suggests a new potential safety risk tied to the drug. But others said the share […]
Read More
Healthy Returns: Weight loss drug race heats up with pill data from Viking Therapeutics, AstraZeneca
Aykut Karahan | Istock | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Happy Friday! Buried in the election news this week was new data from drugmakers vying to enter the booming weight […]
Read More